Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol? "DORIC"


Phase 4 Results N/A

Summary of Purpose

Investigation of the clinical efficacy and safety of dual antiplatelet therapy with clopidogrel and cilostazol versus clopidogrel alone in preventing ischemic vascular events in patients with type 2 diabetes and symptomatic peripheral arterial disease.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 March 2018.

1 Nov 2016 29 Nov 2016 1 Apr 2018 1 Oct 2018 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available


Not available